ScoreComparison
Company
Score
Quality
Valuation
Financial
Technical
Why is Taiko Pharmaceutical Co., Ltd. ?
1
Poor Management Efficiency with a low ROE of 5.99%
- The company has been able to generate a Return on Equity (avg) of 5.99% signifying low profitability per unit of shareholders funds
2
Poor long term growth as Net Sales has grown by an annual rate of -22.96% and Operating profit at -42.86% over the last 5 years
3
With a fall in Net Sales of -57.75%, the company declared Very Negative results in Mar 26
- RAW MATERIAL COST(Y) Grown by 7.49% (YoY)
- NET SALES(Q) Lowest at JPY 916 MM
- OPERATING PROFIT(Q) Lowest at JPY -24 MM
4
With ROE of 9.36%, it has a attractive valuation with a 1.80 Price to Book Value
- Over the past year, while the stock has generated a return of 6.12%, its profits have fallen by -22.6%
5
Underperformed the market in the last 1 year
- The stock has generated a return of 6.12% in the last 1 year, much lower than market (Japan Nikkei 225) returns of 69.64%
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Taiko Pharmaceutical Co., Ltd. for you?
Medium Risk, Low Return
Absolute
Risk Adjusted
Volatility
Taiko Pharmaceutical Co., Ltd.
-100.0%
-0.74
44.72%
Japan Nikkei 225
71.75%
2.62
26.55%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-22.96%
EBIT Growth (5y)
-42.86%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.38
Sales to Capital Employed (avg)
0.64
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
17.96%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
7.85%
ROE (avg)
5.99%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
19
Industry P/E
Price to Book Value
1.80
EV to EBIT
25.91
EV to EBITDA
16.43
EV to Capital Employed
2.35
EV to Sales
1.86
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
9.06%
ROE (Latest)
9.36%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bullish
Dow Theory
No Trend
Mildly Bearish
OBV
No Trend
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend2What is working for the Company
DEBT-EQUITY RATIO
(HY)
Lowest at -40.57 %
DEBTORS TURNOVER RATIO(HY)
Highest at 3.79 times
-23What is not working for the Company
RAW MATERIAL COST(Y)
Grown by 7.49% (YoY
NET SALES(Q)
Lowest at JPY 916 MM
OPERATING PROFIT(Q)
Lowest at JPY -24 MM
OPERATING PROFIT MARGIN(Q)
Lowest at -2.62 %
PRE-TAX PROFIT(Q)
Lowest at JPY -94 MM
NET PROFIT(Q)
Lowest at JPY -95 MM
EPS(Q)
Lowest at JPY -1.89
Here's what is working for Taiko Pharmaceutical Co., Ltd.
Debt-Equity Ratio
Lowest at -40.57 %
in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Debtors Turnover Ratio
Highest at 3.79 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Depreciation
Highest at JPY 73 MM
in the last five periodsMOJO Watch
The expenditure on assets done by the company may have gone into operation
Depreciation (JPY MM)
Here's what is not working for Taiko Pharmaceutical Co., Ltd.
Net Sales
At JPY 916 MM has Fallen at -42.72%
over average net sales of the previous four periods of JPY 1,599.25 MMMOJO Watch
Near term sales trend is extremely negative
Net Sales (JPY MM)
Pre-Tax Profit
At JPY -94 MM has Fallen at -146.25%
over average net sales of the previous four periods of JPY 203.25 MMMOJO Watch
Near term Pre-Tax Profit trend is very negative
Pre-Tax Profit (JPY MM)
Net Profit
At JPY -95 MM has Fallen at -147.24%
over average net sales of the previous four periods of JPY 201.09 MMMOJO Watch
Near term Net Profit trend is very negative
Net Profit (JPY MM)
Net Sales
Lowest at JPY 916 MM
in the last five periodsMOJO Watch
Near term sales trend is negative
Net Sales (JPY MM)
Operating Profit
Lowest at JPY -24 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is negative
Operating Profit (JPY MM)
Operating Profit Margin
Lowest at -2.62 %
in the last five periodsMOJO Watch
Company's profit margin has deteriorated
Operating Profit to Sales
Pre-Tax Profit
Lowest at JPY -94 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is negative
Pre-Tax Profit (JPY MM)
Net Profit
Lowest at JPY -95 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is negative
Net Profit (JPY MM)
EPS
Lowest at JPY -1.89
in the last five periodsMOJO Watch
Declining profitability; company has created lower earnings for shareholders
EPS (JPY)
Raw Material Cost
Grown by 7.49% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
